Z Zoetis Inc
| Market Cap | $51.98B |
| P/E Ratio | 19.62 |
| Forward P/E | 15.63 |
| Dividend Yield | 1.80% |
| Beta | 0.97 |
| 52W Range | $113.35 - $168.42 |
| # Hedge Funds | 6 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Hedge Fund Ownership
| Investor 9 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 2.99% | $699.89M | 5,562,669 | Reduce 26.00% |
| Terry Smith Fundsmith LLP | 2.87% | $490.80M | 3,900,803 | Add 7.90% |
| David Rolfe Wedgewood Partners | 2.46% | $13.17M | 104,701 | Reduce 17.90% |
| William Von Mueffling Cantillon Capital Management | 0.97% | $176.42M | 1,205,716 | — |
| Mairs & Power Growth Fund Mairs & Power Inc | 0.27% | $28.48M | 226,400 | Add 15094.63% |
| FPA Queens Road Small Cap Value Fund Bragg Financial Advisors | 0.02% | $603.00K | 4,793 | Add 46.44% |
| Dodge & Cox Dodge & Cox | 0.00% | $0 | 0 | Sold |
| Jensen Investment Management Jensen Investment Management | 0.00% | $0 | 0 | Sold |
| AKO Capital AKO Capital LLP | 0.00% | $0 | 0 | Sold |
Insider Trading
| Insider Name of the company insider who made the trade 2 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| PECK KRISTIN CChief Executive Officer | Sale | 9,200 | $126.46 | $1.16M | 17 Feb 2026 | 17 Feb 2026 |
| PECK KRISTIN CChief Executive Officer | Sale | 10,800 | $127.55 | $1.38M | 17 Feb 2026 | 17 Feb 2026 |
Frequently Asked Questions
What is ZTS stock price today?
Zoetis Inc (ZTS) is currently trading at $117.94. The stock has a 52-week range of $113.35 to $168.42 and a market capitalization of $51.98B.
Is ZTS a good stock to buy in 2026?
Zoetis Inc has a P/E ratio of 19.6 (forward P/E: 15.6), a dividend yield of 1.80%, and 1-year performance of -25.0%. 9 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ZTS stock?
There have been 2 insider transactions for ZTS in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ZTS stock performed over the past year?
Zoetis Inc (ZTS) has returned -25.0% over the past 12 months. The stock traded between $113.35 and $168.42 during this period, and is currently at $117.94.
Which hedge funds own ZTS (Zoetis Inc)?
9 tracked hedge funds currently hold ZTS in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ZTS's market cap and valuation?
Zoetis Inc (ZTS) has a market capitalization of $51.98B. The trailing P/E ratio is 19.6 and forward P/E is 15.6. The stock is classified in the Healthcare sector.
What is ZTS's revenue and profitability?
Zoetis Inc reported revenue of $9.47B with net income of $2.67B and a profit margin of 0.28%. The stock has a beta of 0.97.
What sector is ZTS in and who are its biggest institutional holders?
Zoetis Inc (ZTS) operates in the Healthcare sector. It is held by 9 tracked hedge funds. See the ownership table above for the complete list.